VIAV (NASDAQ: VIAV) affiliate files Form 144 to sell 3,551 shares

Rhea-AI Filing Summary

VIAV submitted a Form 144 notice reporting the proposed sale of 3,551 restricted common shares. The filing also discloses prior sales of 4,638 common shares on 02/02/2026.

The notice identifies the securities as restricted stock and lists the sale counterparty as the issuer.

Insights

Insider Transactions Specialist

Form 144 shows an affiliate plans to sell 3,551 restricted shares; prior disposals of 4,638 shares are reported.

The filing lists 3,551 restricted common shares under "Securities To Be Sold" with an earlier restricted date of 02/28/2025. It also records a sale of 4,638 common shares on 02/02/2026.

The filing names the counterparty as the issuer; cash‑flow treatment and proceeds recipients are not stated in the excerpt. Subsequent SEC notices or trading reports would show execution details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3551	116792.39	231389345	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2025	Restricted Stock	Issuer			3551	02/28/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PAUL A MCNAB 1445 South Spectrum Blvd Suite 102 Chandler AZ 85286	Common	02/02/2026	4638	119647.41

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did VIAV report in the Form 144?

The Form 144 reports a proposed sale of 3,551 restricted common shares and notes a prior sale of 4,638 shares on 02/02/2026. The securities are identified as restricted stock with an original restricted date of 02/28/2025.

Who is listed as the counterparty for the shares in VIAV's filing?

The filing lists the issuer as the counterparty for the restricted shares to be sold. The excerpt does not state the buyer identity beyond that designation or provide proceeds allocation details.

When were the restricted shares originally granted according to the filing?

The restricted stock grant date shown is 02/28/2025 for the 3,551 restricted common shares. That date is presented in the securities information section of the notice.

How many shares did the filer sell in the past three months?

The filing records a sale of 4,638 common shares on 02/02/2026 under the "Securities Sold During The Past 3 Months" section. The excerpt does not detail transaction price or proceeds.

Does the Form 144 state how proceeds will be used?

The provided excerpt does not disclose any use‑of‑proceeds language. It identifies the securities, quantities, and dates but does not state how cash or value from the proposed sale will be allocated.